DNA Demethylating Agents Suppress Preclinical Models of Synovial Sarcoma

Given that synovial sarcoma is characterized by a peculiarly low DNA hypomethylation profile, researchers hypothesized that further disturbance of DNA methylation would have a negative impact on synovial sarcoma growth.